These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 5741374)
21. A retrospective study of anaemia in neonates exposed to thiopurines in utero. Wiles K; Chandiramani M; Jiwani S; Nelson-Piercy C Gut; 2016 May; 65(5):886-7. PubMed ID: 26715384 [No Abstract] [Full Text] [Related]
22. [Reductional anomalies of the limbs]. Walbaum R LARC Med; 1982 Dec; 2(11):968-77. PubMed ID: 6761523 [No Abstract] [Full Text] [Related]
23. The use of azathiaprine and 6-mercaptopurine (6-MP) as immunosuppressive therapy in inflammatory bowel disease and its role in the etiology of lymphocytic lymphoma. Gelb A; Zalusky R Am J Gastroenterol; 1983 May; 78(5):316. PubMed ID: 6687782 [No Abstract] [Full Text] [Related]
24. [On a special form of extremity malformation in rats following administration of 6-mercaptopurine on day 12 of gestation (author's transl)]. Asisi A; Merker HJ Arzneimittelforschung; 1975; 25(12):1924-6. PubMed ID: 1243664 [TBL] [Abstract][Full Text] [Related]
25. [PRODUCTION OF LIMB MALFORMATIONS IN THE RABBIT BY ADMINISTRATION OF AN ANTIMETABOLITE: AZATHIOPRINE]. TUCHMANN-DUPLESSIS H; MERCIER-PAROT L C R Hebd Seances Acad Sci; 1964 Nov; 259():3648-51. PubMed ID: 14228205 [No Abstract] [Full Text] [Related]
26. [Therapy of chronic inflammatory bowel diseases with azathioprine, 6-mercaptopurine and 6-thioguanine. Clinico-pharmacologic aspects]. Schwab M; Herrlinger K; Schaeffeler E; Stange EF Dtsch Med Wochenschr; 2003 Feb; 128(8):378-85. PubMed ID: 12594624 [No Abstract] [Full Text] [Related]
27. [Damaging effect of 6-mercaptopurine at different stages of embryogenesis in rats]. Vishniakov IuS Farmakol Toksikol; 1968; 31(4):480-1. PubMed ID: 5698140 [No Abstract] [Full Text] [Related]
28. Thiopurine drug adverse effects in a population of New Zealand patients with inflammatory bowel disease. Gearry RB; Barclay ML; Burt MJ; Collett JA; Chapman BA Pharmacoepidemiol Drug Saf; 2004 Aug; 13(8):563-7. PubMed ID: 15317038 [TBL] [Abstract][Full Text] [Related]
29. [Pharmacogenetic study of thiopurine S-methyltransferase (TPMT) and thiopurine toxicity]. Corominas H; Díaz C; Vázquez G; Baiget M Rev Esp Enferm Dig; 2002 Oct; 94(10):635-6. PubMed ID: 12647415 [No Abstract] [Full Text] [Related]
30. Severe pulmonary toxicity after azathioprine/6-mercaptopurine initiation for the treatment of inflammatory bowel disease. Ananthakrishnan AN; Attila T; Otterson MF; Lipchik RJ; Massey BT; Komorowski RA; Binion DG J Clin Gastroenterol; 2007 Aug; 41(7):682-8. PubMed ID: 17667053 [TBL] [Abstract][Full Text] [Related]
32. [Changes in the electrophysiological characteristics of the neuromuscular apparatus in rats with congenital limb deformities]. Tabin VI; Boĭko NA Fiziol Zh (1978); 1983; 29(6):749-53. PubMed ID: 6686160 [No Abstract] [Full Text] [Related]
33. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate. Sandborn WJ Am J Gastroenterol; 1996 Mar; 91(3):423-33. PubMed ID: 8633486 [No Abstract] [Full Text] [Related]
35. [Invasive cancer of the cervix in a patient undergoing chronic treatment with 6-mercaptopurine for Crohns disease]. Alvarez Delgado A; Pérez García ML; Fradejas Salazar PM; de la Coba Ortíz C; Rodríguez Pérez A Gastroenterol Hepatol; 2003 Jan; 26(1):52-3. PubMed ID: 12525330 [No Abstract] [Full Text] [Related]
36. [Teratogenic experiments on the establishment of the sensitive phase of pregnancy in mice]. Frohberg H Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):210-1. PubMed ID: 5804240 [No Abstract] [Full Text] [Related]
37. Protection against cadmium-induced limb malformations by pretreatment with cadmium or mercury. Layton WM; Ferm VH Teratology; 1980 Jun; 21(3):357-60. PubMed ID: 7455925 [No Abstract] [Full Text] [Related]
38. Hypersensitivity to azathioprine mimicking gastroenteritis. Absence of recurrence with 6-mercaptopurine. Godeau B; Paul M; Autegarden JE; Leynadier F; Astier A; Schaeffer A Gastroenterol Clin Biol; 1995 Jan; 19(1):117-9. PubMed ID: 7720971 [TBL] [Abstract][Full Text] [Related]
39. Preventing toxicity with a gene test. Marshall E Science; 2003 Oct; 302(5645):588-90. PubMed ID: 14576416 [No Abstract] [Full Text] [Related]
40. Immunosuppressive therapy of inflammatory bowel disease: a historical perspective. Korelitz BI Gastroenterologist; 1995 Jun; 3(2):141-52. PubMed ID: 7640945 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]